Phase I/II, open-label study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) as monotherapy or combined with ipilimumab in advanced or metastatic solid tumors Meeting Abstract
| Authors: | Callahan, M. K.; Bendell, J. C.; Chan, E.; Morse, M.; Pillai, R. N.; Bono, P.; Jaeger, D.; Evans, T. R. J.; Chau, I.; Calvo, E.; Le, D. T.; Ott, P. A.; Taylor, M. H.; Sharma, P.; Antonia, S. J.; Sharkey, B.; Christensen, O.; Amin, A. |
| Abstract Title: | Phase I/II, open-label study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) as monotherapy or combined with ipilimumab in advanced or metastatic solid tumors |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202052 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.tps3114 |
| Notes: | Meeting Abstract: TPS3114 -- Source: Wos |
